Gene Editing

427.44

-11.2659-2.57%

Number of Gainers:- -

Number of Losers:4

Number of Flat:- -

PE:- -

High:434.55

Open:434.25

Low:423.49

Close:438.71

Volume:9.71M

Turnover:167.28M

Market Cap:9.65B

Float Cap:9.05B

Loading ...

Overview News

Intellia Therapeutics (NTLA) Stock May Be Fully Priced Despite Its 92% Slide

Simply Wall St.

·

Aug 27

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrzen.com/stock/BK4556/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4556","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4556\",,,,,undefined,":{"symbol":"BK4556","market":"US","secType":"PLATE","nameCN":"Gene Editing","latestPrice":427.43945,"timestamp":1789070399999,"preClose":438.70538,"halted":0,"volume":9709721,"delay":0,"changeRate":-0.02568,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed","change":-11.26593,"latestTime":"09-10 16:00:00 EDT","open":434.25467,"high":434.5457,"low":423.48727,"amount":167283761.204566,"amplitude":0.025207,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1789084800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":2.804619,"peRate":-10.111273,"turnoverRate":0.022202,"increases":0,"decrements":4,"flats":0,"marketCap":9645925920,"floatMarketCap":9047133376},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4556\",,,,,undefined,":{"symbol":"BK4556","high":434.5457,"amplitude":0.025207,"preClose":438.70538,"low":423.48727,"pbRate":"2.804619","latestPrice":427.43945,"volume":9709721,"delay":0,"open":434.25467,"prevYearClose":431.70972,"prevWeekClose":475.3505,"prevMonthClose":478.4385,"prevQuarterClose":517.3469,"fiveDayClose":477.7864,"twentyDayClose":447.6086,"sixtyDayClose":476.829,"secType":"PLATE","market":"US","turnoverRate":0.022202,"peRate":-10.111273,"marketCap":9645925920,"floatMarketCap":9047133376,"timestamp":1789070399999,"nameCN":"Gene Editing"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4556\",,,,undefined,":{"bkCode":"BK4556","up":0,"down":4,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4556\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662760725","title":"Intellia Therapeutics (NTLA) Stock May Be Fully Priced Despite Its 92% Slide","url":"https://stock-news.laohu8.com/highlight/detail?id=2662760725","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662760725?lang=en_us&edition=fundamental","pubTime":"2026-08-27 07:38","pubTimestamp":1787787501,"startTime":"0","endTime":"0","summary":"Intellia Therapeutics stock has rebounded over the past year, yet its longer term track record and current valuation checks point to a much less flattering picture. The current market pricing appears rich compared with the broader fundamentals scorecard and the long run return profile.\n\nOver the past 5 years, Intellia Therapeutics shareholders have seen the stock fall about 92%, which puts a spotlight on how much long term value the market believes is still on the table.\nFuture progress on...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ntla/intellia-therapeutics/news/intellia-therapeutics-ntla-stock-may-be-fully-priced-despite","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ntla/intellia-therapeutics/news/intellia-therapeutics-ntla-stock-may-be-fully-priced-despite","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["NTLA","BK4139","BK4588","LU1861559042.SGD","BK4535","TSPA","BK4585","LU1861558580.USD","TACU","CDIG","BK4556"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":3,"totalSize":41,"code":"91000000","status":"200"}]}}